A bioinformatics analysis showed that the level of PPAR-γ was reduced under lipid accumulation conditions [19], and that the activation of PPAR-γ reduced TG levels in patients with NAFLD [49]. The gene discussed is PPARG; the disease is metabolic dysfunction-associated steatotic liver disease.